PVLA 8-K 2026-11-05

PALVELLA THERAPEUTICS, INC. (PVLA) 8-K dated 2026-11-05 — accession 0001193125-26-448594.

PALVELLA THERAPEUTICS, INC. (PVLA) is a biotechnology company listed on NASDAQ.

PALVELLA THERAPEUTICS, INC. filed a 8-K on 2026-11-05. Accession 0001193125-26-448594.

This 8-K covers: Results of operations (Item 2.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported PVLA revenue for 2023-12-31 was $42.8M. Net income was -$24.5M. Revenue was up 65.3% from 2022-12-31 to 2023-12-31. PVLA currently screens at market cap $1.64B.

Not investment advice. The PVLA SEC hub lists recent forms. The stock page is the research view.